Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001415889-24-021240

Options or other derivatives

  • President and CEO acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SIEGALL CLAY B President and CEO 2024-08-09 Grant or award · Stock option (right to buy) +800,000 800,000 D
Loading xslF345X05/form4-08132024_090811.xml…